Karen Schreiber: Advancing Thrombosis Epidemiology Through Global Collaboration at ISTH 2026
Karen Schreiber, Scientific and Clinical Lead at Danish Centre for Expertise in Rheumatology (CeViG) and Danish Hospital for Rheumatic Diseases, shared on LinkedIn:
“The one thing that is most fulfilling in academia is seeing young people grow.
I am so proud of my PhD fellow Dina Husum who has given her first big talk at the ISTH 2026 in Paris this week International Society on Thrombosis and Hemostasis – she nailed it!
Persistence and perseverance pay off.
Rehearsing your talk pays off. Preparation pays off. Believe in what you are doing!
ISTH had allocated 2 slots in the session Epidemiology in Thrombosis – Dina showed amazing results on VTE in patients with RMDs. Publication to follow, watch this space 👀.
Thank you for the amazing collaboration of the project Sigrid Braekkan, Stefano Barco, Savino Sciascia, Massimo Radin, Irene Cecchi, Martje Rave, Bente Glintborg – and thank you to the chairs of the session who were most wonderful Mary Cushman and maranuneztoscano.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy